The coronavirus disease 2019 (COVID-19) pandemic, which is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global public health challenge …

The economical and societal impact of COVID-19 has made the development of vaccines
and drugs to combat SARS-CoV-2 infection a priority. While the SARS-CoV-2 spike protein …

The raging COVID-19 pandemic caused by SARS-CoV-2 has infected tens of millions of
people and killed several hundred thousand patients worldwide. Currently, there are no …

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) helicase NSP13 plays
a conserved role in the replication of coronaviruses and has been identified as an ideal …

The landscape of viral strains and lineages of SARS-CoV-2 keeps changing and is currently
dominated by Delta and Omicron variants. Members of the latest Omicron variants, including …

SARS-CoV-2 infection is still spreading worldwide, and new antiviral therapies are an urgent
need to complement the approved vaccine preparations. SARS-CoV-2 nps13 helicase is a …

The SARS-CoV-2 non-structural protein 13 (nsp13) helicase is an essential enzyme for viral
replication and has been identified as an attractive target for the development of new …

There is currently a lack of effective drugs to treat people infected with SARS-CoV-2, the
cause of the global COVID-19 pandemic. The SARS-CoV-2 Non-structural protein 13 …

The discovery of new drugs for treating the new coronavirus (SARS-CoV-2) or repurposing
those already in use for other viral infections is possible through understanding of the viral …

SARS-CoV-2 non-structural protein 13 (nsp13) is a highly conserved helicase and RNA 5′-
triphosphatase. It uses the energy derived from the hydrolysis of nucleoside triphosphates …